Literature DB >> 16115005

Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.

Mara A Schonberg1, Christina C Wee.   

Abstract

OBJECTIVE: To describe the management of menopausal symptoms and the prevalence of prevention counseling among women who stopped hormone therapy (HT) after publication of the initial findings of the Women's Health Initiative.
METHODS: Telephone survey between July and September 2003 of 142 women 50 years and older, randomly selected from a large academic primary care practice, who stopped taking HT after the WHI publication, July 9, 2002 (66% response rate).
RESULTS: Among 142 women, the median age was 60 years, 63% were white, 52% had at least a college degree, and 60% were taking estrogen and progestin as of July 9, 2002. The majority (82%, n = 117) who stopped HT suffered some menopausal symptom: 25 restarted HT, 13 received another prescription medication, and 56 tried at least one complementary and alternative medicine. Women most commonly used soy (n = 40) or black cohosh (n = 25) for their symptoms, although less than one third of women found either of these treatments effective. Only 49% (57 of 117) of women with symptoms visited a doctor for their symptom. Few women reported receiving counseling about prevention topics after the WHI, such as risk of osteoporosis (34%), risk of heart disease (26%), diet (41%), and exercise (45%).
CONCLUSIONS: Most women who stopped HT after the WHI experienced some menopausal symptoms. Few women found commonly used alternative medicines effective, and few received other prescription medications. Counseling about osteoporosis and heart disease risk was infrequent after the WHI. Future studies should focus on finding safe and effective therapies for menopausal symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16115005     DOI: 10.1089/jwh.2005.14.507

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  4 in total

1.  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.

Authors:  Robert L Brunner; Aaron Aragaki; Vanessa Barnabei; Barbara B Cochrane; Margery Gass; Susan Hendrix; Dorothy Lane; Judith Ockene; Nancy F Woods; Shagufta Yasmeen; Marcia Stefanick
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

2.  The use of alternative methods in reducing menopausal complaints in Turkey.

Authors:  Emel Ege; Halime Esra Kal; Kamile Altuntuğ
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

3.  The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data.

Authors:  Annlouise R Assaf; Andrew G Bushmakin; Nina Joyce; Michael J Louie; Michael Flores; Margaret Moffatt
Journal:  Am Health Drug Benefits       Date:  2017-09

4.  Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women.

Authors:  Markus Lipovac; Peter Chedraui; Christine Gruenhut; Anca Gocan; Christine Kurz; Benedikt Neuber; Martin Imhof
Journal:  Obstet Gynecol Int       Date:  2011-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.